Valerie Morisset

Insider Reports History

Location
Redmond, WA
Signature
/s/ Alan Hambelton, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Valerie Morisset:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eliem Therapeutics, Inc. EVP, R&D AND CSO Common Stock 31,317 $249,910 $7.98 22 Jul 2024 Direct
Eliem Therapeutics, Inc. EVP, R&D AND CSO Stock Option (Right to Buy) 10,198 01 Jul 2024 Direct

Insider Reports Filed by Valerie Morisset

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CLYM Eliem Therapeutics, Inc. 19 Jul 2024 4 -$988,495 4 EVP, R&D AND CSO 23 Jul 2024, 17:04
CLYM Eliem Therapeutics, Inc. 17 Jul 2024 2 -$289,492 4 EVP, R&D AND CSO 19 Jul 2024, 11:12
CLYM Eliem Therapeutics, Inc. 16 Jul 2024 1 -$356,500 4 EVP, R&D AND CSO 17 Jul 2024, 18:11
CLYM Eliem Therapeutics, Inc. 12 Jul 2024 2 -$650,563 4 EVP, R&D AND CSO 16 Jul 2024, 18:14
CLYM Eliem Therapeutics, Inc. 09 Jul 2024 3 -$736,500 4 EVP, R&D AND CSO 11 Jul 2024, 20:45
CLYM Eliem Therapeutics, Inc. 05 Jul 2024 1 -$87,135 4 EVP, R&D AND CSO 09 Jul 2024, 16:46
CLYM Eliem Therapeutics, Inc. 01 Jul 2024 3 -$337,998 4 EVP, R&D AND CSO 03 Jul 2024, 14:42
CLYM Eliem Therapeutics, Inc. 05 Apr 2024 2 +$3.57 4 EVP, R&D AND CSO 08 Apr 2024, 17:33
CLYM Eliem Therapeutics, Inc. 20 Sep 2023 4 +$13.92 4 EVP, R&D AND CSO 04 Mar 2024, 11:07
CLYM Eliem Therapeutics, Inc. 10 Mar 2023 4 +$523 4 EVP, R&D and CSO 14 Mar 2023, 17:04
CLYM Eliem Therapeutics, Inc. 31 Oct 2022 1 $0 4 EVP, R&D and CSO 02 Nov 2022, 19:11
CLYM Eliem Therapeutics, Inc. 27 Jan 2022 1 $0 4 EVP, R&D and CSO 31 Jan 2022, 16:11
CLYM Eliem Therapeutics, Inc. 09 Aug 2021 0 $0 3 Chief Scientific Officer 09 Aug 2021, 18:08